top of page

Search Results

Results found for "Vlaams Instituut Biotechnologie"

  • Dr. Shivani Sachdev | Dr. GPCR Ecosystem

    Sachdev is an early career researcher in the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health. She received her undergraduate degree in Biotechnology from KIIT University in India.

  • Dr. Ralf Jockers | Dr. GPCR Ecosystem

    Ralf Jockers Ralf Jockers studied in Cologne and received a Ph.D. in biotechnology and biochemistry from His laboratory is currently located at the Institute Cochin – Inserm (Paris, France).

  • Dr. Oliver Hartley | Dr. GPCR Ecosystem

    Oliver Hartley Oliver Hartley is VP for Drug Discovery at Orion Biotechnology . Oliver Hartley on the web LinkedIn Orion Biotechnology Dr.

  • Irfan Dhanidina, Dr. Kathleen Caron and Dr. Lauren Slosky | Dr. GPCR Ecosystem

    oncology research led me to pursue a BSc in Biology & Economics from Carleton University, and an MSc in Biotechnology In my role at Orion Biotechnology, I work at the intersection of science and business, which includes Caron currently holds multiple scientific advisory roles in academia, industry and the National Institutes Undergraduate Research Program and is working to build relationships with key stakeholders through institutional

  • Chris Langmead | Dr. GPCR Ecosystem

    Deputy Director, and Better Medicines Theme Leader of the Neuromedicines Discovery Centre at the Monash Institute Prior to these roles this he was Head of Pharmacology at Heptares Therapeutics Ltd., a UK-based biotechnology

  • Dr. GPCR Team | Dr. GPCR Ecosystem

    University of Montreal in Canada before training at Rockefeller University in New York and the National Institutes Sachdev is an early career researcher in the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health. She received her undergraduate degree in Biotechnology from KIIT University in India. GPCR About Cam Sinh Lu Cam Sinh Lu is a PhD student at Monash Institute of Pharmaceutical Sciences, Monash

  • Dr. Timo De Groof | Dr. GPCR Ecosystem

    Timo De Groof studied Biochemistry and Biotechnology at the University of Ghent where he graduated in During his master's studies, he specialized in Biomedical Biotechnology and Structural Biology/Biochemistry

  • Re-cap of Endocrine Metabolic GPCR 2024 with the Organizers | Dr. GPCR Ecosystem

    Her work is currently funded by Biotechnology and Biological Sciences Research Council (BBSRC), Diabetes Caroline Gorvin is a Wellcome Trust & Royal Society Sir Henry Dale Fellow at the Institute of Metabolism

  • Dr. Arun Shukla: How Two Arrestins Regulate 800 GPCRs | Dr. GPCR Ecosystem

    Arun Shukla's lab at the Indian Institute of Technology, Kanpur attacks this question from multiple angles He completed his PhD at the Max Planck Institute of Biophysics in Frankfurt and postdoctoral training Arun Shukla from the Indian Institute of Technology in Kanpur, India. He earned his master's degree in biotechnology from Jawaharlal Nehru University in India and it was during Arun Shukla on the web Indian Institute of Technology Dr.

  • Dr. Hannes Schihada | Dr. GPCR Ecosystem

    in Pharmacy in Regensburg, Germany, I joined the receptor pharmacology group of Martin Lohse at the Institute order to focus my research on class Frizzled GPCR s in the lab of Gunnar Schulte at the Karolinska Institute Hannes Schihada on the web Karolinska Institutet Twitter Adher´n Rise LinkedIn Dr.

  • how-to-build-breakthrough-gpcr-programs | Dr. GPCR Ecosystem

    As co-founder and CEO of Keltic Pharma Therapeutics, he leads a biotechnology company developing a novel

  • Dr. Katarzyna Marcinkiewicz | Dr. GPCR Ecosystem

    following three years on the editorial teams of Nature Structural and Molecular Biology and Nature Biotechnology

  • Revvity | Dr. GPCR Ecosystem

    Elodie Dupuis earned her Master’s degree in biology and biotechnology engineering from the University She has been leading collaborative projects with public research institutes and pharmaceutical companies , most notably the joint Revvity/Institute of Functional Genomics team, EIDOS. Mathis holds a biotechnology engineering degree from the National School of Biomolecule Technology of

  • Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem

    Avanzados del IPN (in English: Center for Research and Advanced Studies of the National Polytechnic Institute Instituto Politécnico Nacional no 2508 Mexico City, C.P. 07360 Room: Auditorium Arturo Rosenblueth *Have

  • Julia Gardner | Dr. GPCR Ecosystem

    Last summer, Julia worked at as the first-ever summer intern at Septerna, the GPCR-based biotechnology

  • Dr. Kathryn E Livingston | Dr. GPCR Ecosystem

    Kathryn E Livingston is currently a Product Manager at Gator Bio , a biotechnology company providing

  • Dr. Arthur Christopoulos | Dr. GPCR Ecosystem

    competitive, charitable and commercial sources, as well as being academic co-founder of three GPCR-focussed biotechnology Additionally, they explored the unique culture and structure of their Institute, highlighting its translational Lastly, they discussed the growth and development of the Monash Institute of Pharmaceutical Sciences, research, highlighting the unique opportunities presented by their location and partnerships with other institutions

  • Dr. Arthur Christopoulos | Dr. GPCR Ecosystem

    competitive, charitable and commercial sources, as well as being academic co-founder of three GPCR-focussed biotechnology Additionally, they explored the unique culture and structure of their Institute, highlighting its translational Lastly, they discussed the growth and development of the Monash Institute of Pharmaceutical Sciences, research, highlighting the unique opportunities presented by their location and partnerships with other institutions

  • Dr. Aylin Hanyaloglu | Dr. GPCR Ecosystem

    Her work is currently funded by Biotechnology and Biological Sciences Research Council (BBSRC), Diabetes

  • Dr. Andrew Tobin | Dr. GPCR Ecosystem

    Andrew is translating fundamental findings to commercial products is Keltic Pharma Therapeutics Ltd , a biotechnology

  • Dr. Patrick Sexton | Dr. GPCR Ecosystem

    Sexton is also a co-founder of the San Francisco-based biotechnology company Septerna Inc . Dr.

  • Dr. Antony A. Boucard Jr | Dr. GPCR Ecosystem

    In this institution dear to the heart of GPCR enthusiasts given that its faculty personnel included Dr integrating the department of Cell Biology at the Centro de Investigación y de Estudios Avanzados del Instituto He also actively volunteers as an Associate Professor of the non-governmental organization Institut des

  • Dr. Josephine (Pina) Cardarelli | Dr. GPCR Ecosystem

    based in South Korea, has recently been named President of GPCR Therapeutics, USA, a newly incorporated Biotechnology

  • Dr. Raul Gainetdinov | Dr. GPCR Ecosystem

    Gainetdinov is the Institute of Translational Biomedicine Director at Saint Petersburg State University Gainetdinov was a Senior Researcher in the Department of Neuroscience and Brain Technologies at the Italian Institute From 2013-2018, he was also a Professor at the Skolkovo Institute of Science and Technology (Skoltech Department of Cell Biology in 1996 as a postdoc and becoming faculty at Duke in 2000, he researched at the Institute 1992 from the Russian Academy of Medical Sciences and an M.D. in 1988 from the Second Moscow Medical Institute

  • The Role of Quantitative Sciences in GPCRs with Dr. Nagarajan Vaidehi | Dr. GPCR Ecosystem

    and chair of the Department of Computational and Quantitative Medicine (DCQM) at the Beckman Research Institute Vaidehi received her Ph.D. in quantum chemistry from the Indian Institute of Technology in India, where became the director of biomolecular simulations at the Materials and Process Simulation Center, Beckman Institute Vaidehi joined the Beckman Research Institute of the City of Hope in 2006 as a Professor and became chair

  • GPCR Assay Strategy, Bias, and Translational Drug Discovery | Dr. GPCR Ecosystem

    His scientific training included a PhD at the International Center for Genetic Engineering and Biotechnology

  • Dr. Kenneth A. Jacobson | Dr. GPCR Ecosystem

    He completed postdoctoral training at the Weizmann Institute. In 1983, he joined the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health, in Bethesda, MD.

  • Dr. Mark Connor | Dr. GPCR Ecosystem

    independent research positions from 2001 at University of Sydney (opioids and sensory neurons), Vollum Institute Portland (visiting scientist with Ed McCleskey, sensory neuron properties); Pain Management Research Institute (more opioids, cannabinoids and T-type Ca channels) and Brain and Mind Research Institute (Sydney).

  • Dr. Antonella Di Pizio: Computational Pharmacology of Taste and Olfactory Receptors | Dr. GPCR Ecosystem

    Antonella Di Pizio — who leads the computational pharmacology group at the Leibniz Institute for Food Biology at the Technical University of Munich, where she was the first group leader appointed to the institute's Di Pizio arrived in October 2018, she founded the first computational group in an institute whose original Antonella Di Pizio, an independent research group leader at the Leibniz Institute for Food Systems Biology Antonella Di Pizio on the web Leibniz-Institute for Food Systems Biology at the Technical University

  • Model. Predict. Discover. with Dr. Jens Carlsson | Dr. GPCR Ecosystem

    Trained initially as a biotechnology engineer, Jens discovered his true calling during an internship

bottom of page